Clinicians must avoid violating professional ethical principles and patients’ legal rights and they may not ever discriminate. So, what does that mean in practice?
AMA J Ethics. 2016;18(3):229-236. doi:
10.1001/journalofethics.2016.18.3.ecas4-1603.
Mark G. Kuczewski, PhD, Johana Mejias-Beck, MD, and Amy Blair, MD
Patients’ immigration concerns can be addressed when clinicians adopt a public health approach to caring: wearing buttons, distributing brochures, inviting experience sharing, and directing patients to needed resources.
AMA J Ethics. 2019;21(1):E78-85. doi:
10.1001/amajethics.2019.78.
Going to so-called safety-net clinics could mean being subject to different standards of care than those in other health care delivery settings. Learners who understand social determinants of health might be able to help patients navigate the system and access community resources.
AMA J Ethics. 2019;21(1):E44-49. doi:
10.1001/amajethics.2019.44.
Regularly scheduled dialysis is not standard of care for most undocumented immigrants in the United States, so preventative care, and advocacy for it, is needed.
AMA J Ethics. 2019;21(1):E86-92. doi:
10.1001/amajethics.2019.86.
AMA Journal of Ethics editor Audiey Kao, MD, PhD, interviewed Richard Pan, MD, MPH, about how, as a physician and legislator, he seeks to protect public health in light of recurrent outbreaks of vaccine-preventable infectious diseases.
Margaret Little, PhD and Anne Drapkin Lyerly, MA, MD
Society is best served by an approach to conscience that combines a progressive understanding of patients’ needs, a nuanced determination of when those needs translate into claims, and a limited role for conscientious refusal.
Physicians, scientists, and public health officials are routinely on the defensive, refuting allegations of unconfirmed risks, justifying the value of vaccines, and striving to preserve public trust in vaccination overall.
Both public health agencies and vaccine companies have a stake in promulgating good information about vaccines: where the government sees gaps in immunization coverage, vaccine manufacturers see gaps in market coverage. Why shouldn't they work together to close them?